Page 34 - World Journal of Laparoscopic Surgery

Evelyn A Dorado et al
glycemia < 100, and glycosylated Hb < 6.5 for a year Table 1: Characteristics of baseline patients
without medication. 8 Patients n = 23
• In hypertension, remission refers to the nonuse of Age, average ± 44 ± 13
medication and normal levels of pressure or a decrease Gender, n (%)
in the amount/frequency of use of antihypertensive Male 11 (48)
agents. 12 Female 12 (52)
• In sleep apnea, no use of CPAP. Comorbidities n (%)
• Hyperlipidemia in the absence of medication and Hypertension 16 (69.5)
normal lipid profile values. Another form of definition OSAHS 9 (39.1)
for the comorbidities was according to the available Hyperlipidemia 11 (48)
5 (22)
Diabetes mellitus
descriptions in their prior medical histories. Others 2 (9)
A postsurgical control was performed after 1 week, Presurgical BMI (%), average ± 42.9 ± 4.3
then 1st, 3rd, 6th, and 12th month postoperative, with Type of procedure, n (%)
the following data being taken: Percentage of weight Sleeve 17 (74)
lost compared with the total body weight, the %EWL Bypass 6 (26)
and whether or not there was any remission in any of Rate of complications 0 (0)
the comorbidities. The categorical variables were repre- Total length of hospital stay, median (IQR) 3 [1–6]
sented with numeric proportions and with medium and Mortality 0 (0)
standard deviations. Comorbidities remission, n (%) 22 (95.6)
Partial remission 7 (32)
RESULTS Complete remission 15 (68)
OSAHS: Obstructive sleep apnea/hypopnea syndrome
The records of 136 patients who received bariatric surgery
were included between January 2014 and January 2016; The %EWL at 1, 6, and 12 months was 35.4 ± 15.2,
the patients who did not suffer comorbidities associated 62.5 ± 17.5, and 79.1 ± 20.2 respectively. With a weight loss of
with obesity and who did not complete 1-year follow-up 14.4 ± 5.3% and comorbidities remission in 52.1% of patients,
were excluded. Twenty-three patients with comorbidities, whether partial or complete, in the 1st month (Table 2).
as documented in their medical records, were included Partial or total ORD remissions are summarized in
(Flow Chart 1). Table 3.
The patients’ mean age was 44 ± 13 years; 52% (12)
were women; 17 (74%) received their bariatric surgery via DISCUSSION
LSG and 6 (26%) via LRYGB; 16 (69.5%) patients suffered
from hypertension; 9 (39%) patients had OSAHS; 11 (48%) Bariatric surgery is the most effective procedure for the
patients had hyperlipidemia; 5 (22%) had other comorbidi- management of morbid obesity and the total or partial
ties, such as osteoarthritis; and hyperuricemia in 2 (9%) resolution of its associated metabolic comorbidities. Both
patients (Table 1). The average initial BMI was 43 ± 4.3 kg/m².
No mortality or associated complications were docu- Table 2: Follow-up time and weight loss percentage
mented for the procedure in this group of patients. The 1 month 6 months 1 year
remission rate was 95.6% (22) of patients and was partial Weight lost (kg), 17.3 ± 8.6 30.4 ± 10.8 38 ± 14.2
and complete in 32 and 68% of patients respectively. average ± SD
Excess weight loss 35.4 ± 15.2 62.5 ± 17.5 79.1 ± 20.2
(%EWL)
Flow Chart 1: Flow diagram
Weight loss percentage 14.4 ± 5.3 25 ± 6.6 31.6 ± 7.9
(%), average ± SD
Comorbidities 12 (52.1) 9 (39.1) 1 (4.3)
remission, n (%)
SD: Standard deviation

Table 3: Partial or total remission per comorbidity
Partial remission Total remission
Comorbidities remission n = 7 n = 15
Hypertension, n = 16 7 (44) 9 (56)
OSAHS, n = 9 5 (55.5) 4 (44.4)
Hyperlipidemia, n = 10 4 (40) 6 (60)
Diabetes mellitus, n = 5 3 (60) 2 (40)
OSAHS: Obstructive sleep apnea/hypopnea syndrome
32